RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
29.97
+0.95 (3.26%)
Oct 8, 2025, 2:33 PM EDT - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $495.55 million as of October 8, 2025. Its market cap has increased by 693.18% in one year.
Market Cap
495.55M
Enterprise Value
328.20M
1-Year Change
693.18%
Ranking
Category
Stock Price
$29.97
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $495.55M, an increase of 79.13%. That is a compound annual growth rate of 10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 479.93M | 125.07% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |